Glutathione-Depleting Pro-Oxidant as a Selective Anticancer Therapeutic Agent
Sign Up to like & getrecommendations! Published in 2019 at "ACS Omega"
DOI: 10.1021/acsomega.9b00140
Abstract: A main challenge in the development of anticancer drugs that eradicate cancer cells specifically with minimal toxicity to normal cells is to identify the cancer-specific properties. Cancer cells sustain a higher level of reactive oxygen… read more here.
Keywords: pro oxidant; b2c; cancer cells; cancer ... See more keywords